Amgen strives to deliver successful treatments to patients. This goes well beyond the development of innovative medicines and preventive therapies. We provide services, advice and new solutions that contribute to a better and more efficient healthcare system. We do this in the following fields:
Oncology and hematology
Particular types of cancer involving tumor formation, such as breast cancer, colorectal cancer, prostate cancer, skin cancer
Hematological types of cancer (cancers of particular blood cells) such as Acute Lymphoblastic Leukemia (ALL) and Multiple Myeloma (MM)
Immune Mediated Trombocytopenia (ITP) - a disease whereby the immune system destroys the body’s own platelets
A shortage of white or red blood cells due to chemotherapy
Severe renal failure in the predialysis or dialysis stage
Osteoporosis - in post-menopausal women and also in men
Bonecomplications caused by bonelesions or bonemetastases (dissemination of cancer in the bone) in patients with advanced cancer.
Elevated LDL cholesterol (the bad cholesterol) in patients with a very high risk of cardiovascular diseases, for whom currently available drugs have not yet succeeded in lowering the LDL cholesterol level sufficiently
Rheumatic diseases such as rheumatoid arthritis
Bowel disorders such as Crohn's disease and Colitis Ulcerosa
Skin diseases such as psoriasis
Eye diseases such as uveitis
In addition, Amgen has developed a range of activities and services that contribute to sustainable care.